NuSynth Technologies Raises ₹36.5 Crore Seed Funding
NuSynth Technologies is developing an AI-driven chemical synthesis platform that uses predictive models and experimental feedback to optimise reaction pathways, improve yields, lower production costs and reduce carbon emissions for pharmaceutical APIs and electronics specialty chemicals.
Mysore-headquartered deep-tech specialty chemicals startup NuSynth Technologies has secured ₹36.5 crore (~$4 million) in a seed funding round co-led by climate-tech investor Avaana Capital and early-stage venture firm Shastra VC.
The startup is building an artificial intelligence-driven chemical process engineering platform designed to redesign complex synthesis pathways, lowering production costs, improving yields, and reducing carbon intensity for industrial chemistry.
At-a-Glance: NuSynth Technologies Funding & Key Metrics
| Metric / Parameter | Details |
| Primary Keyword | NuSynth Technologies funding |
| Funding Round | Seed Round |
| Amount Raised | ₹36.5 Crore (~$4 Million) |
| Lead Investors | Avaana Capital & Shastra VC |
| Founding Date & HQ | Incorporated March 2026 | Mysore (Belagola) & Bengaluru |
| Key Leadership | Poorvank Purohit (CEO), Abhishek Deo (CBO), Dr. Ramesha A. R. (CTO), Dipak Bajaj (COO) |
| Target Industries | Pharmaceuticals (APIs) & Electronics Specialty Chemicals |
| Core Technology | Predictive chemical synthesis models & AI feedback engine |
Redesigning Industrial Chemistry with First-Principles AI
Chemical manufacturing particularly in active pharmaceutical ingredients (APIs) and ultra-pure electronics chemicals remains constrained by legacy synthesis pathways that are resource-heavy, expensive, and environmentally taxing.
NuSynth is addressing these bottlenecks by building a platform that evaluates:
- Reaction Pathway Economics: Simulating alternative chemical synthesis routes to minimize expensive or hazardous raw materials.
- Predictive AI Feedback Loops: Processing experimental lab data in real-time to continuously refine subsequent research cycles, drastically reducing traditional R&D timelines.
- Green & Sustainable Chemistry: Designing process IP that achieves higher atom economy, improved thermal safety, and lower carbon emissions.
Experienced Leadership Driving Deep-Tech Execution
Founded in March 2026, NuSynth is led by a team of seasoned pharmaceutical and chemical industry executives:
- Poorvank Purohit (Founder & CEO): Former Managing Director and CEO of Solara Active Pharma Sciences, bringing extensive experience turning around large-scale API manufacturing businesses.
- Abhishek Deo (Chief Business Officer): Specialist in commercial strategy, business development, and market positioning across specialty chemicals.
- Dr. Ramesha A. R. (Chief Technology Officer): Former NIH (Washington) postdoctoral researcher leading synthetic organic chemistry and process R&D.
- Dipak Bajaj (Chief Operating Officer): Executive overseeing operational execution, pilot plant infrastructure, and regulatory scaling.
Strategic Capital Deployment & Sector Outlook
NuSynth will use the ₹36.5 crore capital injection across four primary operational growth pillars:
- Proprietary Process IP: Building an initial portfolio of patented chemical synthesis processes for high-value pharma and electronics intermediates.
- Scale-Up Infrastructure: Strengthening pilot manufacturing facilities in Karnataka to transition molecules from lab-scale synthesis to commercial production.
- R&D Talent Acquisition: Expanding its team of computational chemists, AI/ML engineers, and process scale-up specialists.
- Commercial Partnerships: Engaging global chemical and pharmaceutical contract development and manufacturing organizations (CDMOs).
The fundraise comes as global supply chains actively seek alternative, cost-competitive, and sustainable specialty chemical manufacturing hubs outside traditional markets, positioning India’s chemical deep-tech ecosystem for rapid acceleration.